Name : Mr.

Shaikh Rahis B2B Code : Sample Collection On :

Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On :
PID No : Prince Diagnostic Centre Report Released On :
Taloja
Referred Dr : Lab id : 01260105546

Abnormal Result(s) Summary

Test Name Result Value Unit Reference Range
Complete Blood Count-CBC
Absolute Lymphocyte Count 5460 /µL 1000 - 3000
Neutrophils 38.30 % 40 - 80
Lymphocytes 54.00 % 20 - 40
HbA1c (Glycosylated Hemoglobin)
HbA1C- Glycated Haemoglobin 11.6 % < 5.7 : Normal
5.7 - 6.4 : Pre Diabetes
> 6.5 : Diabetes
Estimated Average Glucose (eAG) 286.22 mg/dL 70 - 126
Glucose post prandial 290.40 mg/dL 70 - 140
Fasting Glucose-FBS 265.30 mg/dL 70 - 100
LDL- Cholesterol 111.70 mg/dL Optimal: < 100
Near Optimal: 100-129
Borderline high: 130-159
High: 160-189
Very High: >= 190
PROTEIN - TOTAL 6.18 g/dL 6.4 - 8.3
Globulin 2.19 g/dL 2.3 - 3.4
Phosphorous 4.93 mg/dL 2.5- 4.5
Potassium 3.01 mmol/L 3.5 - 5.5
Chlorides 96.40 mmol/L 98-107
Thyroxine (T4) 4.99 µg/dL 5.13 - 14.1
25 Hydroxy (OH) Vit D 12.60 ng/mL Severe Deficiency : < 10.0
Mild Deficiency : 10.0 - 30.0
Sufficiency : 30.0 - 100.0
Toxicity : > 100.0
Abnormal Result(s) Summary End

Page 1 of 16
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:39
Taloja
Referred Dr : Lab id : 01260105546

Investigation Observed Value Unit Biological Reference Interval

Glucose post prandial 290.40 mg/dL 70 - 140
MC-5676 (Plasma - P,Hexokinase)
AS PER AMERICAIN DIABETIC ASSOCIATION 2017 UPDATE:
POSTPRANDIAL /POST GLUCOSE (75 gm)
-Normal Glucose Tolerance : 70 - 140 mg/dl
-Impaired Fasting Glucose : 140 - 199 mg/dl
-Diabetes Mellitus : >= 200 mg/dl
( On more than one occassion)

Page 2 of 16

DR. PRASHANT BASAPURE DR B. N. GORAD

MC-5676 M.D. Path(Mumbai), MBBS MD PATH
D.P.B, 2002/01/0073
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:25
Taloja
Referred Dr : Lab id : 01260105546

Complete Blood Count

Investigation Observed Value Unit Biological Reference Interval
Haemoglobin and RBC Indices
Haemoglobin (Hb) 15.10 g/dL 13.0 - 17.0
MC-5676 SLS Haemoglobin Method(Non Cyanide)
RBC Count 5.30 million/uL 3.50- 5.50
MC-5676 Impedence
PCV 45.00 % 40-50
MC-5676 Calculated
MCV 84.90 fL 83 -99
MC-5676 Impedence
MCH 28.60 pg 27.0 - 32.0
MC-5676 Calculated
MCHC 33.60 g/dL 31.5 - 34.5
MC-5676 Calculated
RDW CV 13.10 % 11.6 - 14.0
MC-5676 Calculated
Total WBC Count 10090 /µL 4000 - 10500
MC-5676 Flowcytometry
Leucocytes
Absolute Neutrophil Count 3860 /µL 2000 - 7000
MC-5676 Calculated
Absolute Lymphocyte Count 5460 /µL 1000 - 3000
MC-5676 Calculated
Absolute Eosinophil Count 190 /µL 20 - 500
MC-5676 Calculated
Absolute Monocyte Count 520 /µL 200 - 1000
MC-5676 Calculated
Absolute Basophil Count 61 /µL < 100
MC-5676 Calculated
Neutrophils 38.30 % 40 - 80
MC-5676 Flowcytometry
Lymphocytes 54.00 % 20 - 40
MC-5676 Flowcytometry
Monocytes 5.20 % 2 - 10
MC-5676 Flowcytometry
Eosinophils 1.90 % 1-6
MC-5676 Flowcytometry
Basophils 0.60 % 00 - 02
MC-5676 Flowcytometry
Platelets
Platelet 276000 /µL 150000 - 450000
MC-5676 Impedence
Page 3 of 16

DR B. N. GORAD
MBBS MD PATH
2002/01/0073
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:25
Taloja
Referred Dr : Lab id : 01260105546

MPV 9.80 fL 6.5 - 12

MC-5676 Calculated
Plateletcrit (PCT) 0.27 % 0.2 - 0.5
MC-5676 Calculated
PDW 16.20 fL 9.0 - 18.0
MC-5676 Calculated
Note:- Kindly note change in reference ranges.

EDTA Whole Blood-Tests done on Automated Five Part Cell Counter. (RBC and Platelet count by impedance/Hydrodynamic
focusing,WBC and differential by VCS technology/Impedance/Flow [Link] are calculated parameters).All Abnormal
Haemograms are reviewed confirmed [Link] count is based on approximately 10,000 cells.

Page 4 of 16

DR B. N. GORAD
MBBS MD PATH
2002/01/0073
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:39
Taloja
Referred Dr : Lab id : 01260105546

HBA1C-Glycated Haemoglobin, blood by HPLC method

(EDTA Whole Blood)

Investigation Observed Value Unit Biological Reference Interval

Fasting Blood Sugar
Fasting Glucose-FBS 265.30 mg/dL 70 - 100
MC-5676 Hexokinase

HbA1C- Glycated Haemoglobin 11.6 % < 5.7 : Normal

MC-5676 HPLC 5.7 - 6.4 : Pre Diabetes
> 6.5 : Diabetes
Estimated Average Glucose (eAG) 286.22 mg/dL 70 - 126

Interpretation & Remark:

1. HbA1c is used for monitoring diabetic control. It reflects the estimated average glucose (eAG).
2. HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 2017, for diagnosis
of diabetes using a cut-off point of 6.5%.
3. Trends in HbA1c are a better indicator of diabetic control than a solitary test.
4. Low glycated haemoglobin(below 4%) in a non-diabetic individual are often associated with systemic inflammatory
diseases, chronic anaemia(especially severe iron deficiency & haemolytic), chronic renal failure and liver diseases.
Clinical correlation suggested.
5. To estimate the eAG from the HbA1C value, the following equation is used: eAG(mg/dl) = 28.7*A1c-46.7
6. Interference of Haemoglobinopathies in HbA1c estimation.
A. For HbF > 25%, an alternate platform (Fructosamine) is recommended for testing of HbA1c.
B. Homozygous hemoglobinopathy is detected, fructosamine is recommended for monitoring diabetic status
C. Heterozygous state detected (D10/ Tosho G8 is corrected for HbS and HbC trait).

7. In known diabetic patients, following values can be considered as a tool for monitoring the glycemic control.
Excellent Control - 6 to 7 %,
Fair to Good Control - 7 to 8 %,
Unsatisfactory Control - 8 to 10 %
and Poor Control - More than 10 % .

Page 5 of 16

DR B. N. GORAD DR. REKHA SHAH

MBBS MD PATH MBBS, DPB
2002/01/0073 Consultant Pathologist.
Bio-Rad CDM System PATIENT REPORT
VII Inst. #1. SN 16344 V2TURBO_A1c_2.0

Patient Data Analysis Data

Sample ID: A257672 Analysis Performed: 13/01/2026 18:35:06
Patient ID: A257672 Injection Number: 2712
Name: Shaikh Rahis Run Number: 28
Physician: Rack ID: 0002
Sex: M Tube Number: 4
DOB: Report Generated: 13/01/2026 18:50:29
Operator ID:
Comments:

NGSP Retention Peak

Peak Name % Area % Time (min) Area
A1a --- 1.2 0.159 22299
A1b --- 1.0 0.220 18321
F --- 1.5 0.252 27405
LA1c --- 2.9 0.382 52539
A1c 11.6* --- 0.478 179274
P3 --- 4.9 0.763 88857
P4 --- 1.6 0.853 28959
Ao --- 76.7 0.980 1377673

*Values outside of expected ranges Total Area: 1,795,327

HbA1c (NGSP) = 11.6* %

20.0

17.5
0.48

15.0
A1c -

12.5
%A1c

10.0
0.76
0.38

7.5
0.22

-
0.85
0.25
-

5.0
0.16
-

-
-

2.5
0.98
-

0.0
-

Page 60.25
0.00 of 16 0.50 0.75 1.00 1.25 1.50
Time (min.)
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:46
Taloja
Referred Dr : Lab id : 01260105546

Iron Studies, Serum

Investigation Observed Value Unit Biological Reference Interval
Iron 88.00 µg/dL 65- 175
MC-5676 (Serum,FerroZine)
Unsaturated Iron Binding Capacity (UIBC) 214.40 ug/dl 110 to 370
MC-5676

Total Iron Binding Capacity (TIBC) 302.40 ug/dl 228 - 428

(Serum,Calculated)
Transferrin Saturation 29.10 % 13 - 45
(Serum,Calculated)

Page 7 of 16

DR. PRASHANT BASAPURE

M.D. Path(Mumbai),
D.P.B,
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:46
Taloja
Referred Dr : Lab id : 01260105546

Lipid Profile
Investigation Observed Value Unit Biological Reference Interval
Cholesterol Total 176.00 mg/dL <200 : Desirable
MC-5676 (Serum,Enzymatic) 200 - 240 : Borderline High
>240 : High
Triglyceride 108.50 mg/dL <150 : Normal
MC-5676 (Serum,Enzymatic) 150 - 199 : Borderline High
200 - 499 :High
>500 : Very High
HDL Cholesterol 42.60 mg/dL Major risk for heart disease
MC-5676 Polyethylene Glycol-Methyl Ether : <40
Negative risk factor for
heart disease : >=60 mg/dl
LDL- Cholesterol 111.70 mg/dL Optimal: < 100
MC-5676 Calculated Near Optimal: 100-129
Borderline high: 130-159
High: 160-189
Very High: >= 190
Cholesterol/HDL Ratio : 4.13 Ratio Low Risk : 3.0 - 4.4
MC-5676 (Serum,Calculated) Average Risk : 4.5 - 7.0
Moderate Risk : 7.1 - 11
High Risk : >11
LDL/HDL Ratio : 2.62 Low Risk : 1.0 -3.0
MC-5676 (Serum,Calculated) Moderate Risk : 3.1 - 6.0
High Risk : >=6.0
VLDL Cholesterol 21.70 mg/dL 5 - 51
MC-5676 (Serum,Calculated)
Non HDL Cholesterol 133 mg/dL Desirable : < 130,
MC-5676
Borderline :130-159
Undesirable : > 160
INTERPRETATION
Lipid profiles should be measured as a part of global risk assessment, and the frequency of checkup is determined by
age, sex, and risk factors for cardiovascular disease.

Page 8 of 16

DR. PRASHANT BASAPURE

MC-5676 M.D. Path(Mumbai),
D.P.B,
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:57
Taloja
Referred Dr : Lab id : 01260105546

Liver Function Test

Investigation Observed Value Unit Biological Reference Interval
Bilirubin Total 0.54 mg/dL 0.2 –1.20
MC-5676 (Serum,Diazo method)
Bilirubin Direct 0.27 mg/dL 0.0 - 0.4
MC-5676 (Serum,Diazo method)
Bilirubin Indirect 0.27 mg/dL 0.0 - 0.7
(Serum,Calculated)
SGPT (ALT) 17.80 U/L 0-45
MC-5676 (Serum,IFCC w/o pyridoxal phosphate activation)
SGOT (AST) 13.20 U/L 0-35
MC-5676 (Serum,IFCC w/o pyridoxal phosphate activation)
PROTEIN - TOTAL 6.18 g/dL 6.4 - 8.3
MC-5676 (Serum,Biuret)
Albumin 3.99 g/dL 3.5 - 5.2
MC-5676 (Serum,Bromocresol green)
Globulin 2.19 g/dL 2.3 - 3.4
MC-5676 Calculated
A/G Ratio 1.82 1.0 - 2.0
MC-5676 Calculated
Alkaline Phosphatase (ALP) 118.00 U/L 53-128
MC-5676 (Serum,Enzymatic)

Page 9 of 16

DR. PRASHANT BASAPURE DR B. N. GORAD

M.D. Path(Mumbai), MBBS MD PATH
D.P.B, 2002/01/0073
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:39
Taloja
Referred Dr : Lab id : 01260105546

Kidney Function Test

Investigation Observed Value Unit Biological Reference Interval
BUN-Blood Urea Nitrogen 15.23 mg/dL 6 - 20
MC-5676 Kinetic with Urease & GLDH
BLOOD UREA 32.60 mg/dL 12.80 - 42.80
MC-5676 Kinetic with Urease & GLDH
Creatinine 0.78 mg/dL 0.70 - 1.30
MC-5676 Kinetic Alkaline Picrate
BUN Creatinine Ratio 19.53 6.0 - 24.0
MC-5676 Calculated
Uric Acid Serum 3.70 mg/dL 3.5 - 7.2
MC-5676 (Serum,Uricase)
Calcium 9.90 mg/dL 8.4 - 10.2
MC-5676 Arsenazol III
Phosphorous 4.93 mg/dL 2.5- 4.5
MC-5676 (Serum,Molybdate UV)
PROTEIN - TOTAL 6.18 g/dL 6.4 - 8.3
MC-5676 (Serum,Biuret)
Albumin 3.99 g/dL 3.5 - 5.2
MC-5676 (Serum,Bromocresol green)
Globulin 2.19 g/dL 2.3 - 3.4
MC-5676 Calculated
A/G Ratio 1.82 1.0 - 2.0
MC-5676 Calculated

Electrolyte
Sodium 141.40 mmol/L 136 - 148
MC-5676 (Serum,ISE Indirect)
Potassium 3.01 mmol/L 3.5 - 5.5
MC-5676 (Serum,ISE Indirect)
Chlorides 96.40 mmol/L 98-107
MC-5676 (Serum,ISE Indirect)

Page 10 of 16

DR. PRASHANT BASAPURE DR B. N. GORAD

MC-5676 M.D. Path(Mumbai), MBBS MD PATH
D.P.B, 2002/01/0073
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:46
Taloja
Referred Dr : Lab id : 01260105546

Estimated Glomerular Filtration Rate

Investigation Observed Value Unit Biological Reference Interval
Creatinine 0.78 mg/dL 0.70 - 1.30
MC-5676 Kinetic Alkaline Picrate
eGFR 116.13 ml/min CKD GFR
MC-5676 Calculated Stage (ml/min/1.73m^2)
1 >= 90
2 60-89
3 30-59
4 15-29
5 <15

IDMS-Traceable MDRD Study Equation for the calculation of GFR:

GFR (mL/minute/1.73 m2) = 175 × (Scr)-1.154 × (age) -0.203 × (0.742 if female) × (1.212 if African American)
(conventional units);
where Scr is serum creatinine.
Note: The equation has not been validated in children and will only be reported for patients >16 years of age. The
equation is normalized for an average adult body surface area of 1.73 m2; weight and height adjustment is not
necessary

Page 11 of 16

DR. PRASHANT BASAPURE

MC-5676 M.D. Path(Mumbai),
D.P.B,
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 18:42
Taloja
Referred Dr : Lab id : 01260105546

Thyroid panel-1 (T3/T4/TSH)

Investigation Observed Value Unit Biological Reference Interval
Tri-iodothyronine (T3) 56.89 ng/dL 35 - 193
MC-5676 (Serum,CMIA)
Thyroxine (T4) 4.99 µg/dL 5.13 - 14.1
MC-5676 (Serum,CMIA)
THYROID STIMULATING HORMONE (TSH) 1.9524 uIU/ml 0.35 - 4.94
MC-5676 (Serum,CMIA)

Page 12 of 16

DR. PRASHANT BASAPURE DR. REKHA SHAH

MC-5676 M.D. Path(Mumbai), MBBS, DPB
D.P.B, Consultant Pathologist.
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 18:33
Taloja
Referred Dr : Lab id : 01260105546

Investigation Observed Value Unit Biological Reference Interval

Vitamin B12 level 400.00 pg/mL 187 - 883
MC-5676 (Serum,CMIA)

Interpretation :

1. Vit B12 levels are decreased in megaloblastic anemia, partial/total gastrectomy, pernicious anemia, peripheral
neuropathies, chronic alcoholism, senile dementia, and treated epilepsy.
2. An associated increase in homocysteine levels is an independent risk marker for cardiovascular disease and
deep vein thrombosis.
3. Holo Transcobalamin II levels are a more accurate marker of active VitB12 component.

Caution:
• Patients on Biotin supplement may have interference in some immunoassays. With individuals taking high dose
Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended.
Disclaimer:
• High levels of Vitamin B12 may be due to exogenous supplementation. Kindly correlate clinically.
Reference:
1. Package insert
2. Arch Pathol Lab Med—Vol 141, November 2017

Page 13 of 16

DR. PRASHANT BASAPURE

MC-5676 M.D. Path(Mumbai),
D.P.B,
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 18:33
Taloja
Referred Dr : Lab id : 01260105546

25 Hydroxy (OH) Vit D 12.60 ng/mL Severe Deficiency : < 10.0

MC-5676 (Serum,CMIA) Mild Deficiency : 10.0 -
30.0
Sufficiency : 30.0 -
100.0
Toxicity : > 100.0

Interpretation:
• Vitamin D is a fat soluble vitamin and exists in two main forms as D3 & D2. Both are converted to 25(OH)
vitamin D in liver.
• For diagnosis of vitamin D deficiency, it is recommended to have clinical correlation with serum 25(OH)vitamin
D, serum calcium, serum iPTH & serum alkaline phosphatase
• During monitoring of oral vitamin D therapy- suggested testing of serum 25(OH) vitamin D is after 12 weeks or 3
months of treatment.
Caution:
• Patients on Biotin supplement may have interference in some immunoassays. With individuals taking high dose
Biotin (more than 5 mg per day) supplements, at least 8-hour wait time before blood draw is recommended.
Disclaimer:
• The required dosage of vitamin D supplements & time to achieve sufficient vitamin D levels show significant
seasonal (especially winter) & individual variability depending on age, body fat, sun exposure, physical activity,
genetic factors (especially variable vitamin D receptor responses), associated liver or renal diseases,
malabsorption syndromes and calcium or magnesium deficiency.
• Vitamin D toxicity is known but very rare. Kindly correlate clinically, repeat with fresh sample if indicated.

Reference:
1. Package insert
2. Arch Pathol Lab Med—Vol 141, November 2017

Page 14 of 16

DR. PRASHANT BASAPURE

MC-5676 M.D. Path(Mumbai),
D.P.B,
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:39
Taloja
Referred Dr : Lab id : 01260105546

Urine examination Routine

Method : Dipstick and Microscopy

Investigation Observed Value Unit Biological Reference Interval

Urine Volume 30 ml
MC-5676

General Examination
Colour Pale Yellow Pale Yellow
MC-5676 Visual
Appearance Clear Clear
MC-5676 Visual
Deposit Absent Absent
Visual

Reaction (pH) Acidic - 5.0 5.0 - 9.0

MC-5676 Double indicator
Specific Gravity 1.025 1.000 - 1.030
MC-5676 Acid Base Indicator
Chemical Examination (Automated Dipstick Method)
Protein Urine Absent Absent
MC-5676 Protein error of indicator
Glucose Urine Absent Absent
MC-5676 Glucose Oxidase
Urine Ketone Absent Absent
MC-5676 Sodium Nitroprusside
Bilirubin Absent Absent
MC-5676 Dichlorobenzene diazonium
Blood Absent Absent
MC-5676 Microscopy
Nitrite Negative Negative
MC-5676 Diazonium
Microscopic Examination
Pus Cells 2-3 cells/HPF 0-5
MC-5676 Microscopy
Epithelial Cells 1-2 cells/HPF 0-5
MC-5676 Microscopy
Red Blood Cells Absent cells/HPF Absent
MC-5676 Microscopy
Yeast Cells Absent Absent
MC-5676 Microscopy
Crystals Absent Absent
MC-5676 Microscopy
Casts Absent Absent
MC-5676 Microscopy
Page 15 of 16

DR. PRASHANT BASAPURE DR B. N. GORAD

M.D. Path(Mumbai), MBBS MD PATH
D.P.B, 2002/01/0073
MMC No 2000031857
 Name : Mr. Shaikh Rahis B2B Code : Sample Collection On : 13-01-2026 15:52
Age/ Gender : 36 Years / Male Sample Collected At : Sample Received On : 13-01-2026 15:52
PID No : Prince Diagnostic Centre Report Released On : 13-01-2026 16:39
Taloja
Referred Dr : Lab id : 01260105546

Bacteria Absent Absent

MC-5676 Microscopy
Others - Absent

1. Urine routine and microscopy is a screening test .

2. Abnormal results of chemical examination are confirmed by manual methods.
3. Pre-test conditions to be observed while submitting the sample- First void, mid-stream urine, collected in a clean, dry, sterile
container is recommended for routine urine analysis, avoid contamination with any discharge from vaginal, urethra, perineum, as
applicable, avoid prolonged transit time & undue exposure to sunlight.
4. During interpretation, points to be considered are Negative nitrite test does not exclude the presence of the bacteria or urinary
tract infections.
5. Trace proteinuria can be seen with many physiological conditions like prolonged recumbency, exercise, high protein diet etc.
6. False reactions for bile pigments, proteins, glucose and nitrites can be caused by peroxidase like activity by disinfectants,
therapeutic dyes, ascorbic acid and certain drugs etc.
7. Physiological variations may affect the test results.
8. The Microscopic examination findings reported are in decimal numbers as they represent arithmetic mean of multiple fields
scanned using cuvette based advanced digital imaging technology.

------------------ End Of Report ------------------

Page 16 of 16

DR. PRASHANT BASAPURE DR B. N. GORAD

M.D. Path(Mumbai), MBBS MD PATH
D.P.B, 2002/01/0073
MMC No 2000031857